- Purified Water (PW) must stay at or below 1.3 µS/cm conductivity and 500 ppb Total Organic Carbon (TOC); Water for Injection (WFI) meets the same chemical limits but adds a strict endotoxin limit of < 0.25 EU/mL that PW does not require (USP).
- Producing pure water is only half the job — WHO GMP guidance on water for pharmaceutical use treats storage and distribution system design (dead-leg minimization, continuous circulation, sanitary fittings) as equally critical to preventing microbial recontamination after purification (WHO TRS 1033, Annex 3).
- Distribution loops are typically sanitized on a schedule using either thermal methods (hot water or pure steam) or chemical methods (commonly ozone, which breaks down to oxygen and leaves no residue); many facilities combine both.
- A complete validation package — Design, Installation, Operational, and Performance Qualification (DQ/IQ/OQ/PQ) — is a regulatory requirement under FDA and WHO guidance, not an optional step, and must be maintained through ongoing monitoring rather than proven once at commissioning.
By the SKE&EAGLE Process Engineering Team
Choosing between Purified Water (PW) and Water for Injection (WFI) production technology is usually the easy part of a pharmaceutical water project. The harder engineering problem is what happens after the water leaves the generation skid: keeping it just as pure through storage, distribution, and use as it was the moment it was produced — and proving to regulators that it stays that way.
This article focuses on that second half of the system: storage tank design, distribution loop engineering, sanitization strategy, and the validation framework that ties it all together. SKE&EAGLE designs purified water systems for the pharmaceutical industry and draws on that experience throughout.
Purified Water vs. Water for Injection: The Grades That Set the Bar
Every distribution and validation decision starts with knowing which grade of water the facility needs to deliver. Purified Water (PW) is used for non-parenteral applications such as oral tablets, topical creams, and equipment cleaning. Water for Injection (WFI) is required wherever water becomes part of a sterile, injectable product, and it carries an additional endotoxin testing requirement under USP General Chapter <85> (USP).
| Feature | Purified Water (PW) | Water for Injection (WFI) |
|---|---|---|
| Conductivity | ≤ 1.3 µS/cm at 25°C | ≤ 1.3 µS/cm at 25°C |
| TOC | ≤ 500 ppb | ≤ 500 ppb |
| Microbial limit | Typically ≤ 100 CFU/mL | ≤ 10 CFU/100 mL |
| Endotoxin | Not specified | < 0.25 EU/mL |
| Typical production | RO + EDI | Distillation or validated membrane systems |
Historically, WFI could only be produced by distillation. Membrane-based (“cold WFI”) systems are now accepted by USP and other major pharmacopeias and use considerably less energy than distillation — but whichever grade a facility produces, the storage and distribution design below applies equally.
Why Storage Tank Design Matters for Purity Retention
A storage tank is not a passive holding vessel — poor tank design is one of the most common sources of recontamination in an otherwise well-purified system. Pharmaceutical storage tanks are built from 316L stainless steel with a mechanically or electropolished interior finish, which gives bacteria far fewer surface irregularities to colonize than a standard tank.
Two details matter beyond the shell material: vent filters, which prevent airborne particles and bacteria from entering the tank as the water level changes, and spray balls, which distribute cleaning and sanitizing fluid evenly across the interior surface during a cleaning cycle. A tank that looks correct on a drawing but omits either feature is a common source of validation failures during commissioning.
Distribution Loop Design: Keeping Water Pure After Production
Once water leaves the storage tank, it typically circulates continuously through a closed loop of piping back to the tank rather than sitting static in a dead-end line. Continuous circulation, rather than intermittent flow, is the core design principle: standing water in a pipe is where biofilm forms, and biofilm is difficult to remove once established.
Distribution loops are engineered around a small set of recurring design rules:
- Minimizing dead legs — short branch pipes off the main loop where water can stagnate. Engineers try to keep these as short as practical relative to the pipe diameter, since any stagnant length is a potential bacterial reservoir.
- Maintaining turbulent, not laminar, flow — flow velocity is sized so water moves fast enough through the loop to discourage bacteria from attaching to pipe walls.
- Sanitary fittings — smooth, orbital-welded or tri-clamp connections rather than threaded joints, which can trap residue and are difficult to fully sanitize.
- 316L stainless steel throughout — for corrosion resistance and compatibility with thermal sanitization cycles.
WHO’s GMP guidance for water used in pharmaceutical manufacturing treats distribution system design as a control point in its own right, not an afterthought to the purification train (WHO TRS 1033, Annex 3).
Sanitization Strategies: Thermal vs. Chemical
Even a well-designed distribution loop needs regular sanitization, and facilities generally choose between two approaches, or combine them.
Thermal sanitization uses hot water (commonly at or above 80°C) or pure steam circulated through the loop. Heat kills bacteria directly and breaks down existing biofilm, and it leaves no chemical residue to test for afterward — the tradeoff is energy cost and the need for materials and gaskets rated for repeated high-temperature cycling.
Chemical sanitization most often uses ozone or peracetic acid at ambient temperature. Ozone is a popular choice because it decomposes into oxygen and leaves no harmful residue, but the facility must validate and document that residual sanitant has fully cleared the system before the water can be used, which adds a testing step that thermal sanitization does not require.
Many pharmaceutical facilities run both: a chemical sanitization cycle for routine maintenance and a periodic thermal cycle as a more aggressive backup against resistant biofilm.
Validation Framework: DQ, IQ, OQ, PQ
A pharmaceutical water system cannot go into service on the strength of a working demo — the FDA and international regulators require documented validation, and that validation has to be maintained, not just performed once. The framework has four stages:
- Design Qualification (DQ) — documents that the proposed system design will actually meet the facility’s water quality and capacity requirements before anything is built.
- Installation Qualification (IQ) — confirms the system was installed as designed, with the correct components, materials, and instrumentation.
- Operational Qualification (OQ) — tests that every component functions correctly across its intended operating range.
- Performance Qualification (PQ) — demonstrates that the system consistently produces water meeting USP specifications over an extended monitoring period, typically covering multiple weeks and operating conditions.
Because PQ is about consistency over time, not a single passing test, ongoing monitoring and periodic re-verification are part of staying validated — a system that passed PQ at commissioning is not permanently validated if it is not routinely re-checked.
Practical Considerations When Specifying a Distribution System
A few decisions early in a project tend to have an outsized effect on how easy the system is to validate and operate later:
- Design the loop and storage tank together, not as separate procurement items — mismatched sizing between tank turnover and loop flow rate is a common cause of stagnation.
- Specify continuous monitoring and electronic records for conductivity, TOC, and (for WFI) endotoxin, rather than relying solely on periodic manual sampling, to simplify both routine operation and PQ documentation.
- Confirm sanitization compatibility before selecting materials — a system intended for thermal sanitization needs gaskets, seals, and instrumentation rated for the sanitization temperature, not just the operating temperature.
None of these add-ons compromise water purity; they reduce the risk of failed validation runs and unplanned system downtime later.
Frequently Asked Questions
What is the difference between Purified Water and Water for Injection?
Both meet the same conductivity and TOC limits. WFI additionally requires testing to confirm it is free of bacterial endotoxins below 0.25 EU/mL, a requirement PW does not carry, because WFI is used in injectable and other sterile products.
Why do distribution loops circulate continuously instead of only running on demand?
Standing water is where biofilm forms. Continuous circulation keeps water moving through the loop at all times, which discourages bacteria from attaching to pipe walls and prevents the stagnant conditions that intermittent flow would create.
What is a dead leg, and why does it matter?
A dead leg is a branch pipe off the main distribution loop where water can become trapped and stop circulating. Because stagnant water is where bacteria and biofilm establish themselves, engineers try to keep dead legs as short as practically possible relative to the pipe diameter.
Is thermal or chemical sanitization better for a pharmaceutical water system?
Neither is universally better — thermal sanitization is highly effective and leaves no residue to test for, but costs more energy and requires heat-rated materials. Chemical sanitization runs at ambient temperature but requires validated testing to confirm the sanitant has fully cleared before use. Many facilities use both.
Does passing Performance Qualification (PQ) mean the system stays validated indefinitely?
No. PQ demonstrates consistent performance over an extended monitoring period at commissioning, but ongoing monitoring and periodic re-verification are required to remain in a validated state — validation is maintained, not achieved once and forgotten.